Merge Labs has emerged from stealth with $252 million in funding to develop non-implantable brain–computer interfaces that use ultrasound and molecular approaches rather than electrodes. The company is cofounded by Sam Altman and is positioned at the intersection of neurotechnology, device engineering, and AI, with OpenAI participating as both an investor and research collaborator.
According to